Harper Scott Q, Staber Patrick D, Beck Christine R, Fineberg Sarah K, Stein Colleen, Ochoa Dalyz, Davidson Beverly L
Program in Gene Therapy, University of Iowa, Iowa City, IA 52242, USA.
J Virol. 2006 Oct;80(19):9371-80. doi: 10.1128/JVI.00958-06.
RNA interference (RNAi) occurs naturally in plant and animal cells as a means for modulating gene expression. This process has been experimentally manipulated to achieve targeted gene silencing in cells, tissues, and animals, using a variety of vector systems. Here, we tested the hypothesis that vectors based on feline immunodeficiency virus (FIV) could be used for coexpression of reporter constructs and RNAi expression cassettes. We found, unexpectedly, in our initial constructs that placement of RNAi expression cassettes downstream from a polymerase II (pol II)-expressed reporter gene inhibited reporter expression but not vector titer. Through a series of intermediate vector constructs, we found that placement of the RNAi expression cassette relative to the Rev response element and the pol II expression cassette was critical for efficient RNAi and reporter gene expression. These results suggested that steric factors, including RNA structure and recruitment of competing transcriptional machinery, may affect gene expression from FIV vectors. In a second series of studies, we show that target sequence silencing can be achieved in cells transduced by FIV vectors coexpressing reporter genes and 3' untranslated region resident microRNAs. The optimized FIV-based RNAi expression vectors will find broad use given the extensive tropism of pseudotyped FIV vectors for many cell types in vitro and in vivo.
RNA干扰(RNAi)作为一种调节基因表达的方式,天然存在于植物和动物细胞中。利用多种载体系统,这一过程已通过实验手段加以操控,以在细胞、组织和动物中实现靶向基因沉默。在此,我们检验了基于猫免疫缺陷病毒(FIV)的载体可用于共表达报告基因构建体和RNAi表达盒的假说。出乎意料的是,在我们最初构建的载体中,我们发现RNAi表达盒置于由聚合酶II(pol II)表达的报告基因下游时,会抑制报告基因的表达,但不会影响载体滴度。通过一系列中间载体构建体,我们发现RNAi表达盒相对于Rev反应元件和pol II表达盒的位置对于有效的RNAi和报告基因表达至关重要。这些结果表明,包括RNA结构和竞争性转录机制募集在内的空间因素可能会影响FIV载体的基因表达。在第二项系列研究中,我们表明,在共表达报告基因和3'非翻译区驻留微小RNA的FIV载体转导的细胞中,可以实现靶序列沉默。鉴于假型FIV载体在体外和体内对多种细胞类型具有广泛的嗜性,优化后的基于FIV的RNAi表达载体将得到广泛应用。